Cheng, Andrew K MD
170 Harbor Way Ste 3
South San Francisco, CA 94080
Akero Therapeutics is a leading cardio-metabolic biotechnology company based in South San Francisco. Specializing in the development of innovative treatments for non-alcoholic steatohepatitis (NASH), the company is dedicated to transforming the landscape of NASH therapy.
With a focus on pioneering solutions for NASH, Akero Therapeutics is at the forefront of cutting-edge research and development in the field of cardio-metabolic disorders. Committed to addressing the unmet medical needs of patients, the company's transformative approach holds promise for those affected by NASH.
Generated from their website's infomation
Also at this address
See a problem?
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.